Flagship @ JPM 2026

Cellarity CEO and Flagship CEO-Partner Ted Myles will present at the J.P. Morgan Healthcare Conference. 

Speakers:

Fred Ramsdell, Ph.D., 2025 Nobel Laureate

Roli Khattri, Ph.D., Senior Vice President, Head of Immunology, Expedition Medicines

Avak Kahvejian, Ph.D., President, Flagship Labs;
General Partner, Flagship Pioneering

Registration Site: https://events.flagshippioneering.com/nobelprizewinningsciencevir

Description: This year’s Nobel Prize in Physiology or Medicine was awarded to three scientists for their groundbreaking work on the human immune system, discoveries that laid the foundation for what is now one of the hottest areas of drug development today: regulatory T-cell centered therapeutics in areas like cancer, autoimmune disease and stem cell transplantation. Flagship general partner Avak Kahvejian will sit down with Nobel Laureate Fred Ramsdell and his post-doc Roli Khattri – now Head of Immunology at Flagship-Founded Expedition Medicines – to discuss the discoveries, the implications for human health, and reflections on what it takes to pursue scientific breakthroughs at the highest level.

In person + Livestream

Speakers:

André Andonian, Chair, Asia-Pacific, and Strategic Advisor, Flagship Pioneering

Irene Cheong, Assistant Chief Executive, Innovation & Enterprise, Agency for Science, Technology and Research (A*STAR)

Christine Heenan, Executive Partner, Executive Operations, Flagship Pioneering

Description: Irene Cheong, Assistant Chief Executive of the Innovation & Enterprise Division at the Agency for Science, Technology and Research (A*STAR), Singapore’s lead public sector R&D agency, will join Flagship Pioneering’s André Andonian, Chair of Asia-Pacific and Strategic Advisor, and Christine Heenan, Executive Partner, Executive Operations, for a forward-looking conversation marking one year of the Flagship–A*STAR partnership. 

The discussion will explore the meaningful progress achieved to date—how the collaboration is already catalyzing innovative research, strengthening entrepreneurial pathways, and accelerating talent development in Singapore and across the Asia-Pacific region. The panelists will also highlight ongoing projects in APAC led by Flagship ecosystem companies and discuss the expanding potential of the partnership as they look ahead to 2026 and beyond.

In-Person Only

Flagship Origination Partner and CEO of Expedition Medicines Molly Gibson will join other leaders for a panel discussion on the application of AI in biotech at the J.P. Morgan Healthcare Conference. 

Speakers:

Justine Levin-Allerhand, Executive Partner, Chief Corporate Development Officer and COO, Flagship Labs, Flagship Pioneering

Nisha Nanda, Group Vice President, Business Development, Head of Catalyze360, Eli Lilly and Company

Misti Ushio, Managing Partner, Digitalis Ventures

Dr. Anita Zaidi, President, Gender Equity Division, Gates Foundation

Registration Site: https://events.flagshippioneering.com/thewomenshealthfrontierfspvir 

Description: Women’s health is one of the most compelling opportunities in healthcare. Demand is strong, key categories remain undercapitalized, and new scientific discoveries and innovations are unlocking novel solutions that can scale across both high-income and emerging markets.

Flagship Pioneering's Justine Levin-Allerhand, Executive Partner, Origination and Corporate Development, will be joined by Nisha Nanda, Group Vice President, Business Development and Head of Catalyze 360, Eli Lilly and Company; Misti Ushio, Managing Partner, Digitalis Ventures; and Dr. Anita Zaidi, President, Gender Equality Division, Gates Foundation, to discuss the commercial drivers to accelerate innovation and capture value in this rapidly growing field.

In person + Livestream

Speakers: 

Noubar Afeyan, Founder & CEO, Flagship Pioneering

Patrick Collison, Co-founder and CEO, Stripe; Co-founder, Arc Institute 

Registration Site: https://events.flagshippioneering.com/futurecastnoubarandpatrickvir

Description: Join Flagship founder and CEO, Noubar Afeyan and Patrick Collison of Stripe and the Arc Institute for a wide-ranging conversation on the ingenuity driving bigger leaps in scientific discovery. They’ll explore the ways in which the future of science — both the means and pace of progress — are being shaped today, the innovative funding models needed to accelerate breakthroughs, and how science and technology are converging in the pursuit of new cures.

In person + Livestream

Speakers:

Patrick Short, Host, The Genetics Podcast

Mike Severino, CEO, Tessera Therapeutics; CEO-Partner, Flagship Pioneering

Michelle Werner, CEO, Alltrna; CEO-Partner, Flagship Pioneering

Description: The promise of genetic medicine has never been greater — or more scrutinized. As the first generation of gene and RNA therapies meets the realities of the clinic and the market, a new wave of companies is advancing technologies that aim to correct disease at its source with greater precision, scalability, and safety.

In this live recording of The Genetics Podcast, host Patrick Short sits down with Mike Severino, CEO of Tessera Therapeutics, and Michelle Werner, CEO of Alltrna, to discuss what’s next for genetic medicine. Both companies are rapidly moving toward the clinic with first-in-class programs, have presented compelling proof-of-concept data for in vivo disease correction, and are navigating an evolving investor landscape in the wake of the first wave of RNA and gene-editing therapeutics.

Together, they’ll explore where conviction and evidence meet in this next chapter of medicine — and what it will take to deliver on the transformative potential of programming biology itself.

In-Person Only

Sana Biotechnology CEO Steve Harr will present at the J.P. Morgan Healthcare Conference.